Skip to main content
. 2017 Nov 27;60(11):359–364. doi: 10.3345/kjp.2017.60.11.359

Table 1. Clinical and biochemical characteristics of 58 obese children.

Characteristic Value
Male sex 38 (65.5)
Age (yr) 11.6±2.9
Weight (kg) 72.9±23.1
Height (cm) 149.9±15.0
BMI z score 5.1±2.2
Waist circumference (cm) 97.5±14.6
Prepubertal stage
 Female:male 3 (5.1):17 (29.3)
Family history of diabetes mellitus 25 (43.1)
Family history of hypertension 28 (48.3)
Family history of dyslipidemia 16 (27.6)
Glucose homeostasis
 Fasting blood glucose (mg/dL) 85.0±7.9
  Impaired fasting glucose 1 (1.7)
  Diabetes 0 (0)
 2-Hour glucose during OGTT (mg/dL) 117.0±18.6
  Impaired glucose tolerance 9 (15.5)
  Diabetes 0 (0)
Insulin
 Fasting insulin (µU/mL) 21.8±13.3
  >15 µU/mL 36 (62.1)
 2-Hour insulin during OGTT (µU/mL) 150.7±113.4
  >75 µU/mL 44 (75.9)
Index for insulin resistance
 HOMA-IR 4.6±2.8
  >3.16 35 (60.3)
Lipid profiles
 Triglyceride (mg/dL) 117.2±65.4
  Hypertriglyceridemia 14 (24.1)
 HDL-cholesterol (mg/dL) 41.4±8.1
  Low HDL 26 (44.8)
 Cholesterol (mg/dL) 183.0±42.4
  Hypercholesterolemia 17 (29.3)
 LDL-cholesterol (mg/dL) 121.4±39.5
  High LDL-cholesterol 18 (31.0)
Inflammatory markers
 hs-CRP (mg/L) 6.37±6.68
  >3 mg/L 40 (69.0)
 IL-6 (pg/mL) 39.1±77.5
 TNF-α (pg/mL) (n=53) 12.1±38.6

Values are presented as number (%) or mean±standard deviation.

BMI, body mass index; OGTT, oral glucose tolerance test; HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high sensitivity C-reactive protein; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha.